Literature DB >> 21103160

Marked improvement in chronic tardive dyskinesia after changing to aripiprazole.

Richard C Christensen1, Lorrie K Garces.   

Abstract

Entities:  

Year:  2006        PMID: 21103160      PMCID: PMC2990560     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


× No keyword cloud information.
  5 in total

1.  Aripiprazole-induced improvement in tardive dyskinesia.

Authors:  Harpreet S Duggal
Journal:  Can J Psychiatry       Date:  2003-12       Impact factor: 4.356

2.  Resolution of Ziprasidone-Related Tardive Dyskinesia With a Switch to Aripiprazole.

Authors:  Ashish Sharma; Sriram Ramaswamy; Vijay K Dewan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

3.  Improvement in tardive dyskinesia with aripiprazole use.

Authors:  James K Witschy; A Scott Winter
Journal:  Can J Psychiatry       Date:  2005-03       Impact factor: 4.356

4.  Maintenance treatment of severe tardive dyskinesia with clozapine: 5 years' follow-up.

Authors:  Mario Rodrigues Louzã; Debora Pastore Bassitt
Journal:  J Clin Psychopharmacol       Date:  2005-04       Impact factor: 3.153

5.  Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum.

Authors:  A Inoue; S Miki; M Seto; T Kikuchi; S Morita; H Ueda; Y Misu; Y Nakata
Journal:  Eur J Pharmacol       Date:  1997-02-19       Impact factor: 4.432

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.